GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Earnings per Share (Diluted)

Invitro International (Invitro International) Earnings per Share (Diluted) : $-0.12 (TTM As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Earnings per Share (Diluted)?

Invitro International's Earnings per Share (Diluted) for the three months ended in Jun. 2097 was $-0.02. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2097 was $-0.12.

Invitro International's EPS (Basic) for the three months ended in Jun. 2097 was $-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2097 was $-0.12.

Invitro International's EPS without NRI for the three months ended in Jun. 2097 was $-0.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2097 was $-0.12.


Invitro International Earnings per Share (Diluted) Historical Data

The historical data trend for Invitro International's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Earnings per Share (Diluted) Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Earnings per Share (Diluted)
Get a 7-Day Free Trial -1.00 -0.56 -0.38 -0.23 -0.15

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.04 -0.04 -0.02 -0.02

Competitive Comparison of Invitro International's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Invitro International's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's PE Ratio distribution charts can be found below:

* The bar in red indicates where Invitro International's PE Ratio falls into.



Invitro International Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Invitro International's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2096 is calculated as

Diluted Earnings Per Share (A: Sep. 2096 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.9-0)/12.667
=-0.15

Invitro International's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2097 is calculated as

Diluted Earnings Per Share (Q: Jun. 2097 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.198-0)/14.028
=-0.01

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2097 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Invitro International  (OTCPK:IVRO) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Invitro International Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Invitro International's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.